In the present study, we therefore investigated for the first time whether hematoma fracture extracts (Hema) and human healthy serum (HH) can promote the osteogenic differentiation of hmrSCs (CD31(−) CD34(−) CD90(−) CD73(+) CD105(+) CD140(−)) induced by BMP9. This evidence concerns the gene GDF2 and hematoma.